Vimarsana
Biggest News Aggregation in the World

Page 6 - Breakthrough Devices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Devices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Devices Today - Breaking & Trending Today

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue - Vimarsana News

CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue

MONMOUTH JUNCTION, N.J., Jan. 18, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening cond...

CMS Repeals MCIT/R&N Final Rule Due to Insufficient Protection - Vimarsana News

CMS Repeals MCIT/R&N Final Rule Due to Insufficient Protection

The Medicare Coverage of Innovative Technology and Definition of Reasonable and Necessary final rule from the Trump admin would have granted expedited Medicare coverage for up to 4 years for certain FDA-designated breakthrough devices having cleared market authorizations.

VUNO Med®-DeepECG™ Designated as Breakthrough Device - Vimarsana News

VUNO Med®-DeepECG™ Designated as Breakthrough Device

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market - Vimarsana News

MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market

/PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostic, and biologics advisory firm and clinical research organization (CRO) integrating U.S....

Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated "Breakthrough Devices" | Nelson Mullins Riley & Scarborough LLP - Vimarsana News

Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated "Breakthrough Devices" | Nelson Mullins Riley & Scarborough LLP

On September 15, 2021, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) published a proposed rule, which (if finalized) would repeal the Agency’s Medicare Coverage...